CNS pipeline · person
Daphne Zohar
Founder and CEO of Seaport Therapeutics. Previously founder and CEO of PureTech Health, where she co-founded Karuna Therapeutics (whose muscarinic agonist Cobenfy was approved for schizophrenia in 2024 and which was acquired by Bristol Myers Squibb).
- 1 company
Courtesy Seaport Therapeutics
Current roles
- Seaport Therapeutics, Inc.Founder, Chief Executive Officer and Board Member · Executive
Appears with
People sharing a company with Daphne.
- Antony Loebel · Seaport Therapeutics, Inc.
- Bob Hombach · Seaport Therapeutics, Inc.
- David Wheadon · Seaport Therapeutics, Inc.
- Denice Torres · Seaport Therapeutics, Inc.
- Eric Green · Seaport Therapeutics, Inc.
- Jason Pitts · Seaport Therapeutics, Inc.
- Jim Healy · Seaport Therapeutics, Inc.
- Lana Gladstein · Seaport Therapeutics, Inc.
- Lauren White · Seaport Therapeutics, Inc.
- Michael Chen · Seaport Therapeutics, Inc.
- Sandi Peterson · Seaport Therapeutics, Inc.
- Sharon Mates · Seaport Therapeutics, Inc.
- Steven Paul · Seaport Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.